US Food and Drug Administration
Scope
Date
~
-
Bio & Pharma
Chong Kun Dang, Synaffix ink deal to introduce ADC technology
Chong Kun Dang Pharmaceutical Corp. said on Monday that it has signed a contract with Dutch biotechnology firm Synaffix B.V for the use of antibody-...
Feb 06, 2023 (Gmt+09:00)
-
Corporate investment
S.Korea's high-tech firms flood to US with heavy spending plans
South Korea’s large business groups are flooding to the US, with their pledged investments there exceeding $100 billion for the next two years...
Feb 06, 2023 (Gmt+09:00)
-
Automobiles
Hyundai GV70 EV to be eligible for US subsidy after classification as SUV
The sport-utility vehicle (SUV) Hyundai Genesis GV70 electric vehicle in the first half of the year is expected to be eligible for subsidies in the ...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong receives approval for its GERD drug Fexuclue in Ecuador
Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...
Feb 06, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
NCSOFT lays off 20% of US operation before new game release
NCSOFT Corp., South Korea’s major game developing and publishing company, has recently laid off about 20% of its North American operation, joi...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's botulinum toxin Nabota proves long-lasting effect
Daewoong Pharmaceutical said on Friday that a high-dose administration of botulinum toxin Nabota (US brand name: Jeuveau) to patients with frown wri...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biopharma submits clinical trial plan in Australia
Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US, has applied to the Australian clini...
Feb 03, 2023 (Gmt+09:00)
-
Business & Politics
Korea’s new EV subsidy plan favors Hyundai over Tesla, other imports
South Korea is revising its electric vehicle subsidy plan in a way that favors local cars such as the Hyundai IONIQ 6 over imported vehicles, includ...
Feb 03, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
MBK, Unison to expand Osstem Implant's target reach beyond China
South Korean private equity firm Unison Capital Korea is set to focus on boosting the corporate value of Osstem Implant Co., once the PE manager and...
Feb 03, 2023 (Gmt+09:00)
-
Automobiles
Hyundai, Kia post record-high Jan. sales figures in US
Hyundai Motor Co. and Kia Corp. posted the highest sales record in the US market in January. Hyundai Motor America said on Wednesday that it sold 52...
Feb 02, 2023 (Gmt+09:00)
-
Food & Beverage
S.Korea's Woowa Brothers launches professional service robot affiliate
Woowa Brothers, the parent company of South Korea's food delivery app Baedal Minjok, on Wednesday spun off its professional service robot unit into ...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US
South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Lunit launches AI-based pathology analysis solution with US firm
South Korea's medical imaging startup Lunit said on Wednesday that it has launched Guardant360 TissueNext, an AI-based pathology analysis solution d...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's InCerebro to leverage AI to identify drug candidates
South Korean AI-based drug developer InCerebro aims to identify potential drug candidates using molecular modeling technology, according to its CEO ...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Daewoong Pharmaceutical to export tech to British company
South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...
Feb 01, 2023 (Gmt+09:00)
-
Banking & Finance
Korea's credit card approval volume hit all-time high last year
The annual card approval amount in South Korea exceeded 1,000 trillion won ($811.4 billion) for the first time ever. This is largely because of "ret...
Feb 01, 2023 (Gmt+09:00)
-
Real estate
Bluecove buys Grand Hyatt Seoul for over $565 million
South Korean real estate firm Bluecove Investment has signed an agreement to acquire five-star hotel Grand Hyatt Seoul for more than 700 billion won...
Jan 31, 2023 (Gmt+09:00)
-
Energy
Korea’s Hyundai Electric wins $86 mn transformer deal in US
Hyundai Electric & Energy Systems Co., a power equipment and energy solution affiliate of the world’s largest shipbuilding group holding c...
Jan 31, 2023 (Gmt+09:00)
-
Retail
Philip Morris, KT&G extend sales partnership to 2038
KT&G Corp., the world's fifth-largest tobacco maker, has extended its sales partnership with US cigarette giant Philip Morris International Inc....
Jan 30, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to put AI into new drug ingredient development
South Korea's drug developer JW Pharmaceutical is expanding the scope of its artificial intelligence (AI) uses from new drug research to the develop...
Jan 30, 2023 (Gmt+09:00)
-
Electric vehicles
Korea’s SK E&S opens 1st US EV charging stations with Avis
South Korea’s SK E&S Co. opened its first electric vehicle charging station in the US in a partnership with Avis Budget Group, a major Ame...
Jan 29, 2023 (Gmt+09:00)
-
Batteries
LG Energy to raise capex by 50% in bet on strong EV growth
LG Energy Solution Ltd., the world’s second-largest electric vehicle battery maker, plans to ramp up capital expenditure by more than half thi...
Jan 27, 2023 (Gmt+09:00)
-
Machinery
Doosan Bobcat opens parts distribution center in Atlanta, Georgia
South Korea's Doosan Bobcat said on Friday that it has opened an additional construction equipment parts distribution center (PDC) in Atlanta, Georg...
Jan 27, 2023 (Gmt+09:00)
-
Shareholder activism
KT&G refuses activist funds' call for ginseng biz spinoff
KT&G Corp., the world’s fifth-largest tobacco maker, on Thursday refused activist funds' requests to spin off and list its ginseng unit wh...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea, Japan compete in gastroesophageal reflux drug market
South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...
Jan 27, 2023 (Gmt+09:00)
-
ECM/DCM
South Korea fines US brokerage $9.6 million for high-frequency trading
South Korea has fined Citadel Securities over 10 billion won ($8.1 million) for disrupting market order through high-frequency trading in the countr...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Earnings
Hyundai vows $8.5 billion investment after record 2022 sales, profit
South Korea’s top automaker Hyundai Motor Co. said on Thursday it will spend 10.5 trillion won ($8.5 billion) this year to ramp up facilities ...
Jan 26, 2023 (Gmt+09:00)
-
Energy
Hanwha Solutions, Microsoft sign solar energy partnership in US
Hanwha Solutions Corp., a unit of South Korea’s chemicals-to-construction conglomerate Hanwha Group, said on Thursday it has formed a strategi...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab launches clinical trials for addiction treatment in Australia
South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...
Jan 26, 2023 (Gmt+09:00)
Latest News
- 1 Google to invest $100 mn in Gentle Monster in smart glasses push
- 2 Growth equity portfolio largely shielded from policy headwinds: Summit
- 3 Naver Financial seeks to acquire Korean real estate data platform Asil
- 4 KakaoBank shares surge on Thai virtual bank approval
- 5 Lotte Biologics signs antibody drug CMO deal with UK’s Ottimo Pharma